TAS-102, a new treatment option for patients with metastatic colorectal cancer that is refractory or intolerant to standard therapies, has been improving survival with acceptable tolerability and adverse event...
http://ift.tt/2fhQPZa
Πέμπτη 3 Νοεμβρίου 2016
Interstitial pneumonia in a patient treated with TAS-102 for metastatic colorectal cancer: a case report
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου